FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2138584803> ?p ?o ?g. }

• W2138584803 endingPage "671" @default.
• W2138584803 startingPage "663" @default.
• W2138584803 abstract "Artemisinin-based combination therapy is the first-line treatment for uncomplicated falciparum malaria. This study assessed the antimalarial efficacy and safety of a combination of 150 mg of arterolane maleate and 750 mg of piperaquine phosphate (AM-PQP) in comparison to Coartem (artemether and lumefantrine) in patients with acute uncomplicated P. falciparum malaria.In this open-label, randomized, multicentric, parallel group clinical trial, 240 patients were randomized to receive AM-PQP (160 patients) or Coartem (80 patients). Patients with P. falciparum monoinfection and initial parasite densities ranging from 1000 to 100 000 asexual parasites/µL of blood were followed for 28 days. Polymerase chain reaction-corrected adequate clinical and parasitologic response on day 28, parasite clearance time, and fever clearance time were evaluated.A total of 151 (94.4%) of 160 patients in the AM-PQP group completed the trial, while 77 (96.3%) of 80 patients in the Coartem group completed the trial. No treatment failure was noted in the AM-PQP group, while one patient receiving Coartem failed treatment on day 28. There was no difference in the median parasite clearance time (30 hours in both groups) or median fever clearance time (24 hours in both groups) after administration of the 2 study treatments.The available data support the evaluation of a drug combination in a larger population as a fixed-dose combination. Clinical Trials Registration. CTRI/2007/091/000031." @default.
• W2138584803 created "2016-06-24" @default.
• W2138584803 creator A5007680932 @default.
• W2138584803 creator A5007697425 @default.
• W2138584803 creator A5011746814 @default.
• W2138584803 creator A5018510690 @default.
• W2138584803 creator A5021986597 @default.
• W2138584803 creator A5023145210 @default.
• W2138584803 creator A5025750533 @default.
• W2138584803 creator A5027297620 @default.
• W2138584803 creator A5027830983 @default.
• W2138584803 creator A5028922022 @default.
• W2138584803 creator A5032990631 @default.
• W2138584803 creator A5034866415 @default.
• W2138584803 creator A5043224438 @default.
• W2138584803 creator A5043230408 @default.
• W2138584803 creator A5047259529 @default.
• W2138584803 creator A5051972045 @default.
• W2138584803 creator A5055529892 @default.
• W2138584803 creator A5056039704 @default.
• W2138584803 creator A5059028284 @default.
• W2138584803 creator A5069051474 @default.
• W2138584803 date "2012-05-14" @default.
• W2138584803 modified "2023-10-08" @default.
• W2138584803 title "Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial" @default.
• W2138584803 cites W1951642591 @default.
• W2138584803 cites W2013035959 @default.
• W2138584803 cites W2052028492 @default.
• W2138584803 cites W2064339010 @default.
• W2138584803 cites W2080892289 @default.
• W2138584803 cites W2095934992 @default.
• W2138584803 cites W2105812381 @default.
• W2138584803 cites W2106346927 @default.
• W2138584803 cites W2127174242 @default.
• W2138584803 cites W2148020902 @default.
• W2138584803 cites W2149251475 @default.
• W2138584803 cites W2161141025 @default.
• W2138584803 cites W71265901 @default.
• W2138584803 doi "https://doi.org/10.1093/cid/cis475" @default.
• W2138584803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22586253" @default.
• W2138584803 hasPublicationYear "2012" @default.
• W2138584803 type Work @default.
• W2138584803 sameAs 2138584803 @default.
• W2138584803 citedByCount "49" @default.
• W2138584803 countsByYear W21385848032013 @default.
• W2138584803 countsByYear W21385848032014 @default.
• W2138584803 countsByYear W21385848032015 @default.
• W2138584803 countsByYear W21385848032016 @default.
• W2138584803 countsByYear W21385848032017 @default.
• W2138584803 countsByYear W21385848032018 @default.
• W2138584803 countsByYear W21385848032019 @default.
• W2138584803 countsByYear W21385848032020 @default.
• W2138584803 countsByYear W21385848032021 @default.
• W2138584803 countsByYear W21385848032022 @default.
• W2138584803 countsByYear W21385848032023 @default.
• W2138584803 crossrefType "journal-article" @default.
• W2138584803 hasAuthorship W2138584803A5007680932 @default.
• W2138584803 hasAuthorship W2138584803A5007697425 @default.
• W2138584803 hasAuthorship W2138584803A5011746814 @default.
• W2138584803 hasAuthorship W2138584803A5018510690 @default.
• W2138584803 hasAuthorship W2138584803A5021986597 @default.
• W2138584803 hasAuthorship W2138584803A5023145210 @default.
• W2138584803 hasAuthorship W2138584803A5025750533 @default.
• W2138584803 hasAuthorship W2138584803A5027297620 @default.
• W2138584803 hasAuthorship W2138584803A5027830983 @default.
• W2138584803 hasAuthorship W2138584803A5028922022 @default.
• W2138584803 hasAuthorship W2138584803A5032990631 @default.
• W2138584803 hasAuthorship W2138584803A5034866415 @default.
• W2138584803 hasAuthorship W2138584803A5043224438 @default.
• W2138584803 hasAuthorship W2138584803A5043230408 @default.
• W2138584803 hasAuthorship W2138584803A5047259529 @default.
• W2138584803 hasAuthorship W2138584803A5051972045 @default.
• W2138584803 hasAuthorship W2138584803A5055529892 @default.
• W2138584803 hasAuthorship W2138584803A5056039704 @default.
• W2138584803 hasAuthorship W2138584803A5059028284 @default.
• W2138584803 hasAuthorship W2138584803A5069051474 @default.
• W2138584803 hasBestOaLocation W21385848031 @default.
• W2138584803 hasConcept C126322002 @default.
• W2138584803 hasConcept C141071460 @default.
• W2138584803 hasConcept C168563851 @default.
• W2138584803 hasConcept C203014093 @default.
• W2138584803 hasConcept C2776120307 @default.
• W2138584803 hasConcept C2776623344 @default.
• W2138584803 hasConcept C2777616469 @default.
• W2138584803 hasConcept C2778048844 @default.
• W2138584803 hasConcept C2778118209 @default.
• W2138584803 hasConcept C2778371730 @default.
• W2138584803 hasConcept C2778629330 @default.
• W2138584803 hasConcept C2780780316 @default.
• W2138584803 hasConcept C2908647359 @default.
• W2138584803 hasConcept C535046627 @default.
• W2138584803 hasConcept C71924100 @default.
• W2138584803 hasConcept C90924648 @default.
• W2138584803 hasConcept C99454951 @default.
• W2138584803 hasConceptScore W2138584803C126322002 @default.
• W2138584803 hasConceptScore W2138584803C141071460 @default.
• W2138584803 hasConceptScore W2138584803C168563851 @default.
• W2138584803 hasConceptScore W2138584803C203014093 @default.

• next